Biotech sector sees increased funding for Q1

04/5/2012 | BioWorld Online (free registration)

For the first three months of the year, U.S. biotech venture funding rounds reached $391 million, a 34% increase to figures for the same period last year, according to BioWorld data. The biggest increases came in support of early-stage innovations: Series A and seed deals brought in 63% more funding in the first quarter. The trend suggests the biotech industry could be a healthier environment for investing in 2012.

View Full Article in:

BioWorld Online (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY